CNBC's Steve Liesman reports protests outside this year's meeting in Jackson Hole are reaching an extraordinary new level.
She will be suitably vague, says Ian Shepherdson, Pantheon Macroeconomics, providing his thoughts on what he expects to hear from Fed Chair Janet Yellen at the economic summit in Jackson Hole. And Glenmede's Jason Pride says the "wheels are in motion" to "nudge" the market into preparation for a rate hike.
Among the events that happened on this day in history, in 1964 President Johnson gets nominated at the Democratic Convention.
Call it crowd-sourcing for algorithmic trading.
Mylan's decision to "gouge" consumers on lifesaving EpiPen devices is corporate "greed on steroids," consumer advocate Ralph Nader tells CNBC.
But Dallas Fed President Robert Kaplan refuses to put a timetable on a possible hike.
Pharmaceutical company Mylan has reduced the cost of EpiPens for some people — but at the end of the day, its CEO told CNBC she has a business to run.
Shares of Mylan held slightly lower in afternoon trade, giving up earlier gains of more than 4 percent.
Mylan announced plans to boost access to its EpiPen Auto-Injector by expanding programs for patients who are facing higher out-of-pocket costs.
Mylan CEO Heather Bresch speaks to CNBC on Thursday about the controversy surrounding her company's 400-percent price hike to EpiPens over the past few years.
Price increases on life-saving EpiPens have parents outraged — but the CEO of the company that makes them said no one's more frustrated than her.
Heather Bresch, Mylan CEO, says lawmakers have not called her back after she reached out to members of Congress. We are doing everything we can to ensure no one goes without an EpiPen, says Bresch.
Jim Cramer is keeping an eye on shares of Mylan after CEO Heather Bresch's CNBC interview where she addressed criticism surrounding the cost of the EpiPen and her frustration with Congress.
Heather Bresch, Mylan CEO, says the fight is on to fix the health care system and she is willing to work with Congress to make it happen.
Heather Bresch, Mylan CEO, says the health care system is broken and if you don't play in the system your products won't get to patients.
Heather Bresch, Mylan CEO, urges changes to update the U.S. health care system and talks about the need to bring down drug costs. Patients are paying twice, says Bresch.
Heather Bresch, Mylan CEO, discusses the need to update the U.S. health care system, and the company's plan to provide an alternate route on pricing.
Heather Bresch, Mylan CEO talks about her frustration with the rising price of drugs.
Heather Bresch, Mylan CEO breaks down the pricing path of the EpiPen and the company's plan to expand access to the drug.
Heather Bresch, Mylan CEO, responds to the controversy surround the company's 400-percent increase for its injectable allergy medicine.
Get the best of CNBC in your inbox
Joe Kernen is co-anchor of "Squawk Box," CNBC's signature morning program.
Becky Quick is co-anchor of "Squawk Box" and also anchor of the nationally syndicated "On the Money."
Andrew Ross Sorkin is a co-anchor of "Squawk Box," a financial columnist for "The New York Times" and the editor-at-large of NYT's DealBook.